- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
16
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
Ascendis Pharma
Market Cap: US$10.7b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$168.17
7D
-2.2%
1Y
23.2%
Alnylam Pharmaceuticals
Market Cap: US$42.3b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$317.50
7D
-1.4%
1Y
24.6%
Exelixis
Market Cap: US$12.0b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$43.51
7D
-0.3%
1Y
96.4%
Insmed
Market Cap: US$18.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$96.14
7D
-1.5%
1Y
36.8%
BeOne Medicines
Market Cap: US$28.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$244.47
7D
-0.3%
1Y
69.1%
Eli Lilly
Market Cap: US$693.8b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$777.66
7D
0.2%
1Y
-16.6%
Vertex Pharmaceuticals
Market Cap: US$118.0b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$466.36
7D
3.1%
1Y
-4.0%
Illumina
Market Cap: US$15.4b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$99.27
7D
1.1%
1Y
-6.9%
AbbVie
Market Cap: US$331.4b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$189.77
7D
-0.1%
1Y
12.9%
Incyte
Market Cap: US$13.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$67.67
7D
-1.5%
1Y
11.5%
Neurocrine Biosciences
Market Cap: US$12.7b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$128.74
7D
0.6%
1Y
-10.2%
Teva Pharmaceutical Industries
Market Cap: US$19.3b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$16.63
7D
-0.06%
1Y
5.2%
Natera
Market Cap: US$21.7b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$158.48
7D
-1.4%
1Y
44.8%
Qiagen
Market Cap: US$10.3b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$47.85
7D
-0.7%
1Y
16.1%
Tempus AI
Market Cap: US$10.1b
Operates as a healthcare technology company.
TEM
US$58.51
7D
-1.1%
1Y
67.2%
Viatris
Market Cap: US$10.8b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$9.26
7D
0.9%
1Y
-14.3%